Q2 FY2026 EarningsQ2 FY2026 results showed a top-line beat with revenue of $306.7M vs. $299.0M expected, driven by adult-use sales in Minnesota and existing market growth. However, GAAP gross margin of 45.0% missed the 47.1% consensus due to brand licensing fees and price compression. Diluted EPS of $0.02 met consensus, supported by a significant reduction in tax expense following the reclassification of cannabis to Schedule III.